Hemlibra
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Hemlibra in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Hemlibra.
29
Global Revenue Ranking
38
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Hemlibra
Results from the study showed that Hemlibra demonstrated ‘clinically meaningful’ bleed control in patients with moderate or mild haemophilia A, without factor VIII inhibitors
The company will present 90 abstracts from across a wide range of haematologic diseases, including results from three pivotal studies in lymphoma and haemophilia
Pharmaceutical sales took a 4% hit in Swiss francs
Blockbuster haemophilia A treatment presents a strong challenge to rival drugs
Halts three studies because of safety concerns
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott
Swiss pharma still managed an 8% increase in pharma sales
Comes on the heels of CMA green light
Roche first announced deal in February
Bad news for Roche as its ageing blockbuster continues to lose ground
Antitrust authorities in both US and UK look likely to end delay
Spark acquisition expected to complete this year
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology